Clinical Trial Update: Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4) [Phase 3]

View source ↗

Summary

Phase III trial of faldaprevir in treatment-naive and relapser Hepatitis C patients co-infected with HIV has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Faldaprevir (faldaprevir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 3 | Status: COMPLETED | Results posted: 2015-09-04